Search

Search Constraints

You searched for: Author/Creator Werner, Jonathan

Search Results

1. 627 The DLL3-targeted half-life extended bispecific T cell engager (HLE BiTE®) immune-oncology therapy AMG 757 has potent antitumor activity in neuroendocrine cancer. (10th December 2020)

2. 627 The DLL3-targeted half-life extended bispecific T cell engager (HLE BiTE®) immune-oncology therapy AMG 757 has potent antitumor activity in neuroendocrine cancer. (9th November 2020)

3. Development of 2-aminooxazoline 3-azaxanthene β-amyloid cleaving enzyme (BACE) inhibitors with improved selectivity against Cathepsin D12. Issue 6 (8th May 2017)

8. Scientific and Regulatory Policy Committee Best Practices*: Documentation of Sexual Maturity by Microscopic Evaluation in Nonclinical Safety Studies. (July 2021)

9. Spontaneous Findings in the Reproductive System of Sexually Mature Male Cynomolgus Macaques. (July 2022)